Salarius Pharmaceuticals, Inc. (SLRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.84M | 0 | 571.39K | 1.27M | 1.48M |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | 100% | - | -100% | -100% | -224.43% | -100% | -54.04% | 12.01% | 42.38% |
| Cost of Goods Sold | 1.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -1.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.84M | 0 | 571.39K | 1.27M | 1.48M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | 100% | - | -100% | -100% | -224.43% | -100% | -54.04% | 12.01% | 42.38% |
| Operating Expenses | 894.02K | 965.57K | 1.72M | 1.49M | 1.01M | 1.47M | 1.77M | 970.7K | 2.53M | 3.97M | 5.42M | 6.48M | 5.62M | 4.76M | 6.12M | 2.3M | 3.75M | 3.69M | 3.07M | 3.24M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -125.24% | - | 645.48% | 242.23% | 218.85% |
| Selling, General & Admin | 832.2K | 849.18K | 1.64M | 1.31M | 869.24K | 1.25M | 1.53M | 910.75K | 1.5M | 1.62M | 1.7M | 1.79M | 1.83M | 1.84M | 1.68M | 1.45M | 1.73M | 1.59M | 1.33M | 1.21M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -78.75% | - | 278.6% | 105.04% | 82% |
| Research & Development | 61.83K | 116.38K | 75.53K | 175.34K | 137.23K | 214.45K | 243K | 59.95K | 1.04M | 2.35M | 3.73M | 4.69M | 3.79M | 2.92M | 4.44M | 2.7M | 2.02M | 2.1M | 1.74M | 2.02M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -146.48% | - | 366.88% | 137.19% | 136.82% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 440 |
| Operating Income | -895.13K | -965.57K | -1.72M | -1.49M | -1.01M | -1.47M | -1.77M | -970.7K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.12M | -4.14M | -3.75M | -3.12M | -1.8M | -1.76M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 225.24% | - | -545.48% | -142.23% | -118.85% |
| Operating Income Growth % | 11.06% | 34.2% | 2.99% | -53.36% | 60.25% | 63.05% | 67.32% | 85.02% | 54.96% | 16.53% | 11.39% | -56.29% | -50.06% | -52.65% | -238.98% | -135.8% | -113.06% | -81.01% | 23.84% | 14.67% |
| EBITDA | -894.02K | -964.46K | -1.72M | -1.49M | -1.01M | -1.47M | -1.77M | -969.6K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.11M | -4.14M | -3.74M | -3.11M | -1.8M | -1.75M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 224.98% | - | -544.64% | -141.85% | -118.49% |
| EBITDA Growth % | 11.07% | 34.23% | 2.99% | -53.43% | 60.21% | 63.06% | 67.33% | 85.03% | 55.05% | 16.59% | 11.34% | -56.43% | -50.21% | -52.94% | -239.62% | -136.25% | -113.3% | -81.17% | 23.91% | 14.76% |
| D&A (Non-Cash Add-back) | 1.11K | 1.11K | 1.11K | 1.11K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | -1.46K | 4.8K | 4.8K | 4.8K | 4.8K | 4.79K | 5.36K |
| EBIT | -873.47K | -965.57K | -1.72M | -1.49M | -1.01M | -1.47M | -1.77M | -970.7K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.12M | -4.14M | -3.75M | -3.12M | -1.8M | -1.76M |
| Net Interest Income | 21.66K | 7.74K | 9.16K | 24.78K | 34.35K | 43.08K | 56.33K | 88.91K | 89.37K | 94.09K | 79.89K | 105.06K | 78.61K | 39.63K | 8K | 0 | 487 | 265 | -1.25K | -2.79K |
| Interest Income | 21.66K | 7.74K | 9.16K | 24.78K | 34.35K | 43.08K | 56.33K | 88.91K | 89.37K | 94.09K | 79.89K | 105.06K | 78.61K | 39.63K | 8K | 0 | 487 | 265 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.25K | 2.79K |
| Other Income/Expense | 21.66K | 7.74K | 9.16K | 24.78K | 34.35K | 43.08K | 56.33K | 88.91K | 89.37K | 94.09K | 79.89K | 106.94K | -8.79M | 39.63K | 8K | 39.98K | 9.56K | 42.45K | -47.3K | -9.78K |
| Pretax Income | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M | -1.77M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 223.06% | - | -538.05% | -145.95% | -119.52% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M | -1.77M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 223.06% | - | -538.05% | -145.95% | -119.52% |
| Net Income Growth % | 10.15% | 32.76% | 0.34% | -66.02% | 60.2% | 63.26% | 67.88% | 86.16% | 83.05% | 17.82% | 12.58% | -55.2% | -285.58% | -53.47% | -229.89% | -132.24% | -117.7% | -72.31% | 11.13% | 6.12% |
| Net Income (Continuing) | -873.47K | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M | -1.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.81 | -6.75 | -15.45 | -22.80 | -11.40 | -35.55 | -49.05 | -26.85 | -78.15 | -171.75 | -267.60 | -43.20 | -769.20 | -270.00 | -396.00 | -270.00 | -250.80 | -210.00 | -180.00 | -42.60 |
| EPS Growth % | 84.12% | 81.01% | 68.5% | 15.08% | 85.41% | 79.3% | 81.67% | 37.85% | 89.84% | 36.39% | 32.42% | 84% | -206.7% | -28.57% | -120% | -533.8% | 16.4% | 46.15% | 72.73% | 80.28% |
| EPS (Basic) | -1.81 | -6.75 | -15.45 | -22.80 | -11.40 | -35.55 | -49.05 | -26.85 | -78.15 | -171.75 | -267.60 | -43.20 | -769.20 | -270.00 | -396.00 | -270.00 | -250.80 | -210.00 | -180.00 | -42.60 |
| Diluted Shares Outstanding | 481.59K | 142.23K | 111.48K | 64.47K | 85.89K | 40.23K | 35.13K | 32.98K | 31.44K | 22.69K | 20.03K | 18.87K | 18.82K | 17.93K | 15.49K | 15.15K | 15.01K | 14.99K | 10.23K | 6.96K |
| Basic Shares Outstanding | 481.59K | 142.23K | 111.48K | 64.47K | 85.89K | 40.23K | 35.13K | 32.98K | 31.42K | 22.69K | 20.03K | 18.83K | 18.82K | 17.89K | 15.49K | 15.15K | 15.01K | 14.94K | 10.23K | 5.56K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |